2025 North America Adult And Pediatric Vaccines Market Revenue Opportunities Report
Description
The 2025 North America Adult And Pediatric Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in North America are Pfizer, Merck & Co., Johnson & Johnson, and Moderna. Pfizer leads with a significant vaccine portfolio, including their flagship COVID-19 mRNA vaccines and other vaccine candidates for diseases like meningococcal and influenza. Merck & Co. is renowned for vaccines like Gardasil (HPV) and MMR (measles, mumps, rubella), contributing significantly to its $53.6 billion human health revenue in 2023. Johnson & Johnson, through its Janssen Pharmaceuticals division, develops vaccines such as the Ebola vaccine and COVID-19 adenovirus-based vaccine, with strong involvement in infectious disease R&D. Moderna is notable for its pioneering mRNA vaccine technology, primarily COVID-19 vaccines, positioning it as an innovator in vaccine development.
Together, these companies shape the North American vaccines market, which was valued at $18 billion in 2023 and is expected to grow to $32.1 billion by 2033. Their strategies include continued R&D investment, launching pediatric vaccines, and developing novel vaccine technologies such as mRNA platforms. Pfizer, Merck, and Johnson & Johnson have a broad, established vaccine base, while Moderna contributes innovation that accelerates market growth. This dynamic supports strong immunization programs and responses to infectious disease outbreaks across North America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in North America are Pfizer, Merck & Co., Johnson & Johnson, and Moderna. Pfizer leads with a significant vaccine portfolio, including their flagship COVID-19 mRNA vaccines and other vaccine candidates for diseases like meningococcal and influenza. Merck & Co. is renowned for vaccines like Gardasil (HPV) and MMR (measles, mumps, rubella), contributing significantly to its $53.6 billion human health revenue in 2023. Johnson & Johnson, through its Janssen Pharmaceuticals division, develops vaccines such as the Ebola vaccine and COVID-19 adenovirus-based vaccine, with strong involvement in infectious disease R&D. Moderna is notable for its pioneering mRNA vaccine technology, primarily COVID-19 vaccines, positioning it as an innovator in vaccine development.
Together, these companies shape the North American vaccines market, which was valued at $18 billion in 2023 and is expected to grow to $32.1 billion by 2033. Their strategies include continued R&D investment, launching pediatric vaccines, and developing novel vaccine technologies such as mRNA platforms. Pfizer, Merck, and Johnson & Johnson have a broad, established vaccine base, while Moderna contributes innovation that accelerates market growth. This dynamic supports strong immunization programs and responses to infectious disease outbreaks across North America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
